Development and Advantages of O -(Carboxymethyl)- L -tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer
Journal of Medicinal Chemistry · 23.07.2026 · 69 (14) · 16268-16278
DOI: 10.1021/acs.jmedchem.6c00960 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 08.07.2026. Verfasst von Linlin Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Molecular Imaging Laboratory, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Glutamate Carboxypeptidase II, Antigens, Surface, Radiopharmaceuticals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Beijing Anzhen Hospital High-Level Research Specialized Discipline Construction Project - Nuclear Medicine, Beijing Anzhen Hospital High Level Research Funding.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Molecular Imaging Laboratory, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
- Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union, Beijing 100730, China.
- Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong, China.
- Department of Nuclear Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
- College of Chemistry, Beijing Normal University, Beijing 100875, China.
- Five Eleven Pharma Inc., 3700 Market St., Philadelphia, Pennsylvania 19104, United States.
ORCID-Profile: Lin Zhu, Zhaohui Zhu, Hank F Kung
Förderung
- Beijing Anzhen Hospital High-Level Research Specialized Discipline Construction Project - Nuclear Medicine
- Beijing Anzhen Hospital High Level Research Funding
Zitieren
APA
Li, L., Zhao, R., Wang, G., Jin, W., Zhu, L., Zhu, Z., & Kung, H. F. (2026). Development and Advantages of O -(Carboxymethyl)- L -tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer. Journal of Medicinal Chemistry, 69(14), 16268-16278. https://doi.org/10.1021/acs.jmedchem.6c00960
Vancouver
Li L, Zhao R, Wang G, Jin W, Zhu L, Zhu Z, et al. Development and Advantages of O -(Carboxymethyl)- L -tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer. Journal of Medicinal Chemistry. 2026;69(14):16268-16278. doi:10.1021/acs.jmedchem.6c00960
BibTeX
@article{Li2026,
author = {Li, Linlin and Zhao, Ruiyue and Wang, Guochang and Jin, Wenbin and Zhu, Lin and Zhu, Zhaohui and Kung, Hank F},
title = {Development and Advantages of O -(Carboxymethyl)- L -tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {14},
pages = {16268--16278},
doi = {10.1021/acs.jmedchem.6c00960}
}
EUVIMED